OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi or Single-Kinase Inhibitors to Counteract Drug Resistance in Cancer: What is New?
Camilla Pecoraro, Daniela Carbone, Stella Cascioferro, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 7, pp. 776-782
Closed Access | Times Cited: 8

Showing 8 citing articles:

Quinazoline‐chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in‐silico studies of potential anticancer activity against multiple myeloma
Mostafa A. Mansour, Asmaa M. AboulMagd, Samar H. Abbas, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 2

Synthesis of Novel Nilotinib Analogues and Biological Evaluation of Their Antiplatelet Activity and Functionality towards Cancer Cell Proliferation In Vitro
L. Pechlivani, Nikoleta Ntemou, Despoina Pantazi, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 349-349
Open Access | Times Cited: 2

The Role of Death-Associated Protein Kinase-1 in Cell Homeostasis-Related Processes
Lilian Makgoo, Salerwe Mosebi, Zukile Mbita
Genes (2023) Vol. 14, Iss. 6, pp. 1274-1274
Open Access | Times Cited: 4

Inhibition of GCN2 Reveals Synergy with Cell-Cycle Regulation and Proteostasis
Gregory Gauthier-Coles, Farid Rahimi, Angelika Bröer, et al.
Metabolites (2023) Vol. 13, Iss. 10, pp. 1064-1064
Open Access | Times Cited: 3

Design, synthesis, biological evaluation, and in silico studies of novel pyridopyridine derivatives as anticancer candidates targeting FMS kinase
Anusha Sebastian, Reinad R. Abu Rabah, Seyed–Omar Zaraei, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116557-116557
Closed Access

Recent Development of CDK2 Inhibitors as Anticancer Drugs: An Update (2015–2023)
Yumei Jin, Hao Lu, Ge Hu, et al.
Pharmaceutical Fronts (2024) Vol. 06, Iss. 03, pp. e195-e220
Open Access

Discovery of A Potent Anticancer Agent against Pancreatic Ductal Adenocarcinoma Targeting FAK with DFG-out State and JAK/Aurora Kinases
Rong‐Hong Zhang, Ting Chen, Qianqian Xiong, et al.
European Journal of Medicinal Chemistry (2024) Vol. 282, pp. 117059-117059
Closed Access

Src Tyrosine Kinase Inhibitory and Antioxidant Activity of Black Chokeberry and Bilberry Fruit Extracts Rich in Chlorogenic Acid
Sanda Vladimir‐Knežević, Maja Bival Štefan, Biljana Blažeković, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15512-15512
Open Access

Page 1

Scroll to top